PlainRecalls
FDA Drug Moderate Class II Terminated

Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ

Reported: April 5, 2017 Initiated: March 15, 2017 #D-0617-2017

Product Description

Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ

Reason for Recall

Failed Dissolution Specifications; 9 month long term stability

Details

Units Affected
32628 bottles
Distribution
Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 32628 bottles.
Why was this product recalled?
Failed Dissolution Specifications; 9 month long term stability
Which agency issued this recall?
This recall was issued by the FDA Drug on April 5, 2017. Severity: Moderate. Recall number: D-0617-2017.